CRISPR/Cas9-mediated knock out of ITGB6 in human OSCC cells reduced migration and proliferation ability
Abstract Background The treatment of oral squamous cell carcinoma (OSCC) remains challenging and survival rates have not been improved significantly over the past decades. Integrins have been recognized driving the cancer progression and high expression levels cause poor outcomes in patients afflict...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-06-01
|
| Schriftenreihe: | Head & Face Medicine |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13005-024-00437-x |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
